Clarus Therapeutics announced that the FDA has approved Jatenzo (testosterone undecanoate capsules for oral use) (CIII) for testosterone replacement therapy...
Testosterone deficiency (TD) is an increasingly common problem with significant health implications, but its diagnosis and management can be challenging.
The FDA cautions that prescription testosterone products are approved only for men who have low testosterone levels caused by certain...
Background: Atrial fibrillation (AF) is the most common cardiac dysrhythmia associated with significant morbidity and mortality. Several small studies have reported that low serum total testosterone (TT) levels were associated with a higher incidence of AF.